Middle East - Israel

Shibolet & Co.

More informationMore information

Shibolet & Co.’s varied offering assists a broad client list, consisting of domestic incubators, academic institutions, and investment companies. Ofer Ben-Yehuda leads the team alongside Einat Weidberg. Ben-Yehuda is noted for his expansive transactional expertise, regularly assisting clients with venture capital financings, private placements, and strategic alliances. Weidberg regularly acts for both Israeli and overseas clients in mandates concerning cross-border M&A, public offerings, and corporate debt finance. Regulatory and crisis management specialist Amos Bentzur advises HMOs and both public and private healthcare systems on the full range of operational matters.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘The office is characterised by the pleasant atmosphere of a team that works together for the benefit of the client. The firm employs lawyers who specialise in many fields, and thus provides a broad response, covering all required aspects.’

  • ‘Tal Karplus has vast experience and knowledge in his areas of expertise. Karplus is very pleasant and approachable to his clients and also creates a cooperative working atmosphere with the opposite party.’

Key clients

  • Biontech SE
  • Lts Pharmaceutical Solutioms
  • Jiangsu Aiyimu Medtech Co., Ltd.
  • Second Skin
  • Dele Health Tech As
  • China-Israel Biological Technology Co., Ltd.
  • Noya Therapeutics Limited
  • American Ortho
  • Grindeks
  • Gilead Sciences Israel
  • Innovestgenetics Gmbh
  • Lexington Medical Inc
  • Pregnantech LTD
  • Chengdu Kanghong Pharmaceutical Co., Ltd.
  • OBCTCD 24 Ltd.
  • Pluristem Ltd.
  • Nobio Ltd
  • VUZE medical
  • CartiHeal (2009) Ltd.
  • The Trendlines Group Ltd.
  • Elron Electronic Industries Ltd.
  • Alon Medtech Ventures Ltd.
  • BeyeOnics Surgical Ltd.
  • OrthoSpin Ltd.
  • NovoCure (Israel) Ltd.
  • Technion Research and Development Foundation Ltd. and Technion Investment Opportunities Fund
  • Ancora Medical
  • ApiFix Ltd.
  • RDD Pharma Ltd.
  • Compugen Ltd.
  • DiA Imaging Analysis Ltd.
  • Ballet Vision Ltd.
  • Emulait Inc.
  • Clalit Health Services
  • Pi-Cardia Ltd.

Work highlights

  • Represented Dia Imaging Analysis Ltd. in its acquisition by Koninklijke Philips N.V. for up to US$75m. The deal involved adjusting to the acquirer's procedures while protecting the interests of the client and its securityholders, including publicly traded companies.
  • Advising CartiHeal (2009) Ltd., a technology company, on clinical trials, commercial agreements, and complex strategic transactions. The firm advised the client on a put/call option transaction with Bioventus LLC, which faced funding difficulties, leading to an extensive amendment.
  • Represented Floris Ben Shimon Ltd. and its shareholders in the sale of 100% of their shares to C.T.S. Ltd. for NIS 60M in an all-cash deal. The transaction involved a competitive bidding process, complex negotiations, and discussions with the Israel Competition Authority for regulatory consents.

Practice head

The lawyer(s) leading their teams.

Ofer Ben-Yehuda, Einat Weidberg

Other key lawyers

Tal Karplus, Amos Bentzur, Daniel Kariv, Gal Shnaiberg